Resources
![Cover page in blue with title and image of people sitting on the ground listening to.a training](/sites/default/files/styles/max_325x325/public/2022-09/screen_shot_2022-09-07_at_8.42.05_am.png?itok=fHV6twUQ)
Microplanning manual to guide implementation of preventive chemotherapy to control and eliminate neglected tropical diseases
WHO manual on implementing preventative chemotherapy against neglected tropical diseases provides generic tools for those involved in planning preventative chemotherapy administration. The publication was released in September 2022.
![Cropped image of document cover page](/sites/default/files/styles/max_325x325/public/2022-08/screen_shot_2022-08-15_at_3.14.17_pm.png?itok=OBPni42q)
WHO standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy
New WHO standard operating procedures--released on July 25, 2022--describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them.
WHO guideline on control and elimination of human schistosomiasis
New WHO guideline--released on February 14, 2022--outlines guidelines for preventive chemotherapy, safety of praziquantel for treatment, WASH and snail control interventions and verification of interruption of transmission of human schistosomiasis.
Effect of preventive chemotherapy with praziquantel on SCH among school age children in sub-Saharan Africa: a spatiotemporal modelling study
Christos Kokaliaris, Amadou Garba, Martin Matuska, Rachel N Bronzan, Daniel G Colley, Ameyo M Dorkenoo, Uwem F Ekpo, Fiona M Fleming, Michael D French, Achille Kabore, Jean B Mbonigaba, Nicholas Midzi, Pauline N M Mwinzi, Eliézer K N'Goran, Maria Rebollo Polo, Moussa Sacko, Louis-Albert Tchuem Tchuenté, Edridah M Tukahebwa, Pitchouna A Uvon, Guojing Yang, Lisa Wiesner, Yaobi Zhang, Jürg Utzinger, Penelope Vounatsou,
Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study, The Lancet Infectious Diseases, 2021, ISSN 1473-3099,
https://doi.org/10.1016/S1473-3099(21)00090-6.
![Model overview](/sites/default/files/styles/max_325x325/public/2020-09/Screen%20Shot%202020-09-10%20at%206.06.33%20AM.png?itok=gIqrSsiC)
Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs
The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.